FOR IMMEDIATE RELEASE 1 June 2004
CHEMRING GROUP PLC
AWARD OF CONTRACT FOR SHIPBORNE COUNTERMEASURES
Chemring Group PLC ('Chemring') is pleased to announce that its UK
countermeasures business, Chemring Countermeasures, ('CCM'), has been awarded a
£12 million contract by the UK Ministry of Defence for the design and supply of
an improved shipborne countermeasure for deployment in Royal Navy frigates,
destroyers and larger ships. Following an initial design certification phase,
deliveries under the contract are anticipated to commence in 2008.
David Evans, Chief Executive of Chemring, commented: 'This contract, which is
the culmination of both trials and design activity over a number of years, is
the largest shipborne countermeasures contract ever placed with CCM. The new
round will break new ground by being the first application of fully insensitive
munition (IM) technology in the countermeasures field of ship defence, and we
anticipate that it will attract considerable interest from overseas navies.'
Chemring is an international leader in defensive countermeasures, signalling
and training pyrotechnics and marine safety products. Chemring's
countermeasures division comprises Alloy Surfaces Company, Inc. and Kilgore
Flares Company LLC in the US, and Chemring Countermeasures in the UK.
For further information:
David Evans Chief Executive, Chemring Group PLC 01489 881880
Jonathan Rooper CardewChancery 0207 930 0777
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.